Related Experiment Videos
Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma
K R Hess1, M C Abbruzzese, R Lenzi
1Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Summary
A novel analytical method, classification and regression tree (CART) analysis, identified key prognostic factors for unknown primary carcinoma (UPC) patients. This approach effectively stratified patients into distinct survival groups, aiding future clinical trial design.
Area of Science:
- Oncology
- Biostatistics
- Clinical Research
Background:
- Clinical features and survival times for unknown primary carcinoma (UPC) are highly variable.
- Effective prognostic factor identification is crucial for managing UPC patients.
Purpose of the Study:
- To apply a novel analytical method, classification and regression tree (CART) analysis, to a cohort of UPC patients.
- To identify novel prognostic factors, explore clinical variable interactions, and illustrate their impact on survival.
- To segregate UPC patients into homogeneous subgroups for enhanced clinical trial stratification.
Main Methods:
- Multivariate survival analyses were performed using classification and regression tree (CART) analysis on 1000 UPC patients.
- CART analysis was utilized to identify prognostic variables and create distinct patient subgroups based on clinical features and survival.
- Data were collected from patients referred to the University of Texas M. D. Anderson Cancer Center between 1987 and 1994.
Main Results:
- The median survival for all 1000 UPC patients was 11 months.
- CART analysis identified 10 terminal subgroups with median survival ranging from 40 months to 5 months.
- Key prognostic variables included liver involvement, metastatic organ sites, histology, and age, which effectively segregated patients into groups with similar clinical features and survival.
Conclusions:
- Classification and regression tree (CART) analysis is a valuable method for dissecting complex clinical situations in unknown primary carcinoma (UPC).
- CART effectively identified previously unappreciated patient subsets and stratified patients into homogeneous groups.
- This approach facilitates the identification of suitable patient populations for future clinical trials and improves prognostic accuracy.